Keck Graduate Institute

KECK GRADUATE INSTITUTE SELECTS DR. MOHAMED ABOUSALEM AS ITS THIRD PRESIDENT

Retrieved on: 
Tuesday, March 12, 2024
Research, University, Organization, Innovation, Growth, Civil engineering, Science, Health, Assistant, Regenerative medicine, Trustee, Education, History, CIRM, SJSU, Engineering, KGI, Knight Foundation, MBA, SAN, Silicon, Claremont Colleges, Alexandria University, Santa Clara University, Sheldon Schuster, Keck Graduate Institute, Marketing, Management

As the Vice President for Research and Innovation at San José State University (SJSU), Dr. Abousalem provided executive leadership to the growth of the university’s research and innovation enterprise.

Key Points: 
  • As the Vice President for Research and Innovation at San José State University (SJSU), Dr. Abousalem provided executive leadership to the growth of the university’s research and innovation enterprise.
  • Dr. Abousalem has held several executive roles for organizations in Silicon Valley and Canada, leading product and corporate development, general management, marketing communications, and human resources of several worldwide business operations.
  • "I am thrilled and privileged to have been chosen to lead KGI at this exciting and transformational time in its history," Dr. Abousalem said.
  • and Ph.D. in Geomatics Engineering from the University of Calgary, Canada, and an MBA from Santa Clara University.

Larta Institute Opens Call for Applications to Heal.LA Bioscience and Healthcare Accelerator

Retrieved on: 
Wednesday, November 8, 2023
Other Health, General Health, Professional Services, Entrepreneur, Philanthropy, Consumer, Start-Up, Small Business, Science, Biotechnology, Other Philanthropy, Health, Other Science, Knowledge, Rancho Los Amigos National Rehabilitation Center, Health care, Therapy, Food, Healing environments, Mental health, USC, Heal, California State University, Organization, Holism, Entrepreneurship, Gilead Sciences, Small business, Consortium, Medicine, Cedars-Sinai Medical Center, Keck Graduate Institute, Rio Hondo College, Innovation Hub, Keck School of Medicine of USC, SBA, California Office of Environmental Health Hazard Assessment, WuXi Biologics, Hospital, Management, New England Biolabs, Pediatrics

Larta Institute, a non-profit organization accelerating innovation and entrepreneurship to feed, fuel and heal the world, has opened a call for applicants to join the 2024 cohort of its Heal.LA Bioscience and Healthcare Accelerator.

Key Points: 
  • Larta Institute, a non-profit organization accelerating innovation and entrepreneurship to feed, fuel and heal the world, has opened a call for applicants to join the 2024 cohort of its Heal.LA Bioscience and Healthcare Accelerator.
  • The Heal.LA accelerator welcomes applications from innovators with ideas that have the potential to improve the health and wellness of underserved, urban communities.
  • Larta has designed our Heal.LA Bioscience and Healthcare Accelerator to help diverse founders advance innovations geared to the needs of underserved communities and to pilot the use of their solutions in these communities.
  • To learn more or apply to the Heal.LA Bioscience and Healthcare Accelerator, please visit: https://larta.org/programs/heal-accelerator/

ProfoundBio Readies for Next Phase of Growth with Management Team Additions and Advisory Board Appointment

Retrieved on: 
Thursday, November 2, 2023
Research, Thought Leadership, Clinical Trials, Professional Services, Biotechnology, Health, Pharmaceutical, Science, Oncology, IPO, Pharmacyclics, Catalent, Alder, Therapy, Hematology, Nutcracker, MBS, Head, CMC, Seagen, Lundbeck, University of California, Acquisition, PTK7, Protein, Economics, Lundbeck Seattle Biopharmaceuticals, Yale University, Immunotherapy, Growth, SITC, ADC, Division, University, Biology, Amgen, Baxter International, Internal medicine, Merrill (company), Business, Keck Graduate Institute, Society for Immunotherapy of Cancer, Genentech, Society, Cancer, Seattle, University of Southern California, Coronavirus Scientific Advisory Board, Fine chemical, Management, Biochemistry, Proteolix, Chiron, Spacecraft, Western Washington University

We are thrilled to welcome Erin and Kevin to our leadership team as we plan for this next stage of growth.

Key Points: 
  • We are thrilled to welcome Erin and Kevin to our leadership team as we plan for this next stage of growth.
  • In addition, as chair of our Scientific Advisory Board, Lori brings decades of clinical thought-leadership and strategic product development experience in ADCs.
  • We look forward to working alongside them.”
    ProfoundBio also announced additional changes to the company's executive team.
  • Co-founders Tae Han and Xiao Shang will take on the roles of chief strategy officer and head of CMC, respectively.

Persephone Biosciences Appoints Daniel Bradbury as Chair of the Board of Directors

Retrieved on: 
Monday, October 23, 2023
Oncology, Health, Other Science, Pharmaceutical, Science, Biotechnology, Persephone, Allergy, United Kingdom, Veronica, Janssen, University of Nottingham, Amylin Pharmaceuticals, DSM-IV codes, Management, Diabetes, Acquisition, General partnership, Research, Infant, Trustee, Keck Graduate Institute, Marketing, Executive, Bristol Myers Squibb, University, Bachelor of Pharmacy, Education, Therapy, Intercept Pharmaceuticals, Pharmaceutical industry, Pharmacy

Persephone Biosciences Inc., a biotechnology company reimagining patient health through the development of microbiome-based medicines, today announced that it has appointed Daniel Bradbury as Chair of the Board of Directors.

Key Points: 
  • Persephone Biosciences Inc., a biotechnology company reimagining patient health through the development of microbiome-based medicines, today announced that it has appointed Daniel Bradbury as Chair of the Board of Directors.
  • Additionally, Persephone has a further two clinical studies underway, namely our ARGONAUT study of gut microbiome-linked immune modulation in cancer treatment response, and our AMBROSIA food-as-medicine study.
  • “As Chair, Dan brings his vast experience as a serial entrepreneur, spanning both public and private biotechs, to our company.
  • In addition, Mr. Bradbury serves on the Keck Graduate Institute’s Board of Trustees and the University of California San Diego’s Rady School of Management Dean’s Advisory Council.

AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors

Retrieved on: 
Monday, September 18, 2023
Executive, Research and development, Drug development, Keck Graduate Institute, United States Air Force Scientific Advisory Board, IP, Doctor of Philosophy, Development, Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine, Acadia Pharmaceuticals, European, Growth, FFB, UCLA, FDA, Therapy, Management, Allergan, Health

COSTA MESA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today announced the appointment of Dr. Lester J. Kaplan, PhD to its board of directors.

Key Points: 
  • COSTA MESA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today announced the appointment of Dr. Lester J. Kaplan, PhD to its board of directors.
  • Dr. Kaplan served as the Executive Vice President and President, Research & Development and Global Botox, and a board member of Allergan.
  • “I am honored and excited to welcome Dr. Kaplan to the board of directors.
  • Dr. Kaplan’s long history of leadership and deep experience in drug development will be invaluable to AiViva BioPharma,” said Diane Tang-Liu, PhD, President and CEO of AiViva.

Dr. Kiana Aran makes Inc.'s 2023 Female Founders list

Retrieved on: 
Tuesday, April 4, 2023
CRISPR, Food, Female, Therapy, Biosignal, Medical diagnosis, Woman, Keck Graduate Institute, KGI, Associate, Bangladesh Technical Education Board, Rutgers University, Organization, Scientist, Patient, Rihanna, SNP, SAN, Pleasure, Shoe, BPU, NIH, Pharmaceutical industry, Science

SAN DIEGO, April 4, 2023 /PRNewswire/ -- Inc. today announced its sixth annual Female Founders list, honoring a bold group of 200 women whose innovations and ideas are shaping the world into a better place.

Key Points: 
  • SAN DIEGO, April 4, 2023 /PRNewswire/ -- Inc. today announced its sixth annual Female Founders list, honoring a bold group of 200 women whose innovations and ideas are shaping the world into a better place.
  • Winner of the 2021 Nature Award for Inspiring Women in Science, Dr. Kiana Aran, makes Inc.’s 2023 Female Founders list.
  • Being recognized as a top female founder motivates me to continue pushing the boundaries of science and technology."
  • "These 200 female founders have identified solutions to difficult problems and created valuable, industry-changing companies out of them.

Cartography Biosciences Appoints Chester Wong as VP, Head of Business Development

Retrieved on: 
Thursday, February 23, 2023
Oncology, Health, Health Technology, Research, Science, Pharmaceutical, Biotechnology, Medicine, University, Berkeley, Astellas Pharma, Antigen, Malignancy, Business, Patient, Therapy, Hematology, Business development, Multimedia, Keck Graduate Institute, Onyx Pharmaceuticals, Cell biology, Management, Fine chemical, Amgen, List of life sciences

Cartography Biosciences, a precision medicine company creating therapeutics guided by the first-ever comprehensive single-cell antigen atlas for immuno-oncology targets, today announced the appointment of Chester Wong as Vice President, Head of Business Development.

Key Points: 
  • Cartography Biosciences, a precision medicine company creating therapeutics guided by the first-ever comprehensive single-cell antigen atlas for immuno-oncology targets, today announced the appointment of Chester Wong as Vice President, Head of Business Development.
  • View the full release here: https://www.businesswire.com/news/home/20230223005443/en/
    “We are thrilled to welcome Chester to the Cartography team,” said Kevin Parker, Ph.D., Co-founder and CEO of Cartography Biosciences.
  • He joins Cartography from Amgen, where as Director of Business Development he led the execution of several key deals across a wide range of areas including opportunities within oncology, hematology, and immunology.
  • Previously he served on the corporate development team at Onyx Pharmaceuticals, an Amgen subsidiary, and held key roles at Astellas Pharma and Deallus Consulting.

Framework Solutions Launches Medical Affairs Division with Appointment of Key Executive

Retrieved on: 
Thursday, October 6, 2022
TMAC, Growth, LLC, Executive, Technology, Knowledge, Axxess Technology Solutions, Medical Affairs Bureau, Industry, Principal, CEO, Richard Barker (life sciences and healthcare leader), Pharming, Executive director, Dean (education), Medicine, Adviser, Global Medical Excellence Cluster, Keck Graduate Institute, List of life sciences, Compliance, Medical device, Management, Amgen, Framework

D., as Executive Vice President, Medical Affairs, effectiveOctober 3, 2022.

Key Points: 
  • D., as Executive Vice President, Medical Affairs, effectiveOctober 3, 2022.
  • "Norm is an accomplished Medical Affairs leader with a proven track record of success.
  • Dr. Enriquez is an experienced Medical Affairs biotech executive, clinician, and entrepreneur with a proven track record of success in building and leading high performing medical teams.
  • Dr. Enriquez' extensive past experience included tenures at CytomX Therapeutics (Vice President, Medical Affairs), The Medical Affairs Company (Principal, TMAC Advisors), Amgen (Executive Director, Global Medical Development),and Sanofi / Aventis (Director, Field-based Medical).

Hound Labs Names Tamanna Prashar as Chief Operating Officer

Retrieved on: 
Tuesday, August 30, 2022
Benchmark, COO, Keck Graduate Institute, University, Public health, CEO, EEC, Technology, Research, Solution, Culture, Champaign–Urbana metropolitan area, Executive, Department, Lucira, Usha Prashar, Baroness Prashar, MBA, GLOBE, SAFETY, Icon Ventures, Workplace, Company, Cannabis, Substance Abuse and Mental Health Services Administration, Champaign County, Illinois, COVID-19, Law enforcement, DOT, Substance Abuse, Automation, SAMHSA, Employment, Drug, Management, Science, IPO

OAKLAND, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Hound Labs, Inc., a leader in ultra-sensitive, automated, accurate, and analytical technologies and creator of the HOUND CANNABIS BREATHALYZER, welcomes Tamanna Prashar as Chief Operating Officer (COO).

Key Points: 
  • OAKLAND, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Hound Labs, Inc., a leader in ultra-sensitive, automated, accurate, and analytical technologies and creator of the HOUND CANNABIS BREATHALYZER, welcomes Tamanna Prashar as Chief Operating Officer (COO).
  • She comes to Hound Labs from Lucira Health, where she was the Executive Vice President of Operations and Supply Chain.
  • I am honored to join the team at Hound Labs and look forward to working to further the mission of balancing SAFETY AND FAIRNESS in the workplace, states Prashar.
  • Later this year, Hound Labs will begin delivering its first on-site solution the HOUND CANNABIS BREATHALYZER,1 which allows employers and law enforcement to identify recent cannabis use.

Kriya Appoints Curt Herberts as President and Chief Operating Officer

Retrieved on: 
Thursday, August 25, 2022
Health, Health Technology, Genetics, Research, Science, Pharmaceutical, Biotechnology, Partnership, Ophthalmology, Therapy, Keck Graduate Institute, Entrepreneurship, Conditional sentence, Herberts, Multimedia, Triangle Park (Quezon City), Sangamo Therapeutics, Biology, Stanford University, Silicon, Professional Science Master's Degree, Business, Industry, Patient, Pharmaceutical industry, Science, Kriyā

Kriya Therapeutics, Inc. , a fully integrated gene therapy company advancing a broad portfolio of innovative therapeutics, announced today that it has appointed Curt Herberts, M.B.S., as President and Chief Operating Officer.

Key Points: 
  • Kriya Therapeutics, Inc. , a fully integrated gene therapy company advancing a broad portfolio of innovative therapeutics, announced today that it has appointed Curt Herberts, M.B.S., as President and Chief Operating Officer.
  • Herberts will oversee all general and administrative functions at Kriya.
  • Curt and I will be working in close partnership to build value for patients, investors, and employees.
  • Herberts joins Kriya from Senti Biosciences, Inc., where he was Chief Financial Officer and Chief Business Officer from 2018 to 2021, and Chief Operating Officer from 2021 to 2022.